BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 11, 2013
View Archived Issues
Ono Pharmaceutical reports highlights of second quarter of fiscal 2013
Read More
Lundbeck reflects on active third quarter 2013
Read More
Nuvilex acquires rights to cellulose-based live-cell encapsulation technology for diabetes
Read More
Anti-LOXL2 antibody suppresses collagen cross-linking and fibrosis progression in vivo
Read More
Advanced Proteome Therapeutics achieves milestone in cancer program
Read More
University of Virginia to study PTP-01 as imaging agent for pancreatic cancer
Read More
Phase II clinical data demonstrate efficacy for an antibody to treat adipocytic sarcoma
Read More
ACEA Biosciences' AC-0025 shows antiarthritic activity in vivo
Read More
Novel tyrosine-protein kinase inhibitors patented by Advinus Therapeutics
Read More
Dainippon Sumitomo Pharma prepares new 11-beta-HSD1 inhibitors
Read More
New cathepsin S inhibitors disclosed by Astellas Pharma
Read More
Biodel advances ultra-rapid-acting insulin product BIOD-531 into clinical development
Read More
New fusion proteins to reactivate apoptosis in TRAIL/Apo-2L-resistant cancer cells described
Read More
New Hsp70 inducers presented by scientists in the Netherlands
Read More
Drug repositioning detects efficacy of drugs for malaria
Read More
Immuron cleared to conduct trial of IMM-124-E for alcoholic steatohepatitis
Read More
Eisai and Broad Institute to develop new drugs for neglected tropical diseases
Read More
Discovery Laboratories begins U.S. launch of Surfaxin
Read More
CereSpir acquires rights to cognitive impairment treatment candidate
Read More
FDA clears CERC-301 for phase II study in major depression
Read More
Grifols to acquire Novartis' transfusion diagnostics unit
Read More
GW Pharmaceuticals initiates phase Ib/IIa study of cannabinoids for glioblastoma multiforme
Read More
FDA approves Aptiom as adjunctive treatment for partial-onset seizures
Read More
Eisai launches Aciphex Sprinkle in U.S.
Read More
Shire to acquire ViroPharma
Read More
Salix Pharmaceuticals to acquire Santarus
Read More